Research facility · founded 1941
Texas Biomedical Research Institute
San Antonio, United States · txbiomed.org
- Citations, last 5 years
- 9 120
- Works, last 5 years
- 1 021
- h-index
- 440
- Scientists listed
- 0
- Grants since 2016
- 265
Grants received
2025–2030 · research · R01
Use of Focused ultrasound stimulated blood brain barrier opening for CNS HIV/SIV reservoir reduction
Jason T. Kimata · Texas Biomedical Research Institute · funded by National Institutes of Health
2025–2035 · contract · N01
EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES
Ricardo Carrion · Texas Biomedical Research Institute · funded by National Institutes of Health
2025–2030 · research · R01
Targeted CRISPR/Cas Editing to Eliminate SIV CNS Reservoir in Methamphetamine-Exposed Rhesus Macaques on ART
Wenhui Hu · Texas Biomedical Research Institute · funded by National Institutes of Health
2025–2030 · research · R01
Evaluating the safety, immunogenicity and efficacy of a robust attenuated Mtb vaccine in the setting of HIV co-infection
Deepak Kaushal · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma
Deepak Kaushal · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme
Diako Ebrahimi · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Intrarectal Immunization for a Barrier to Mucosal HIV Infection
Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Impact of HIV on the human alveolar environment drivingthe early events of Mycobacterium tuberculosis infection
Larry S. Schlesinger · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection
Smriti Mehra · Texas Biomedical Research Institute · funded by National Institutes of Health
2024 · grant · Academic Research
Stimulate Mucosal-associated Invariant T cells to Kill Cancer Cells
Shouxiong Huang · Texas Biomedical Research Institute · funded by Cancer Prevention and Research Institute of Texas
2024–2025 · program · P51
The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areas
Larry S. Schlesinger · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2025 · research · R56
Effect of IL-21 treatment concurrent to ART and 3HP in Mtb/SIV co-infection
Riti Sharan · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2025 · research · R01
Impact of HIV on the human alveolar environment drivingthe early events of Mycobacterium tuberculosis infection
Larry S. Schlesinger · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme
Diako Ebrahimi · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma
Deepak Kaushal · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection
Smriti Mehra · Texas Biomedical Research Institute · funded by National Institutes of Health
2024–2029 · research · R01
Intrarectal Immunization for a Barrier to Mucosal HIV Infection
Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas
Blanca I Restrepo · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2025 · research · R56
Donor-specific anti-HIV/SIV immunity mediated by APOBEC3 enzymes
Diako Ebrahimi · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2026 · research · R21
Novel antiviral strategy offering forward capability and reduced risk of escape
Andrew Hayhurst · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2025 · research · R03
Determining the Functional Significance of Mutations Observed in Envelope Protein Following Serial In Vivo Passaging of Human-Simian Immunodeficiency Virus
Rajesh Thippeshappa · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
M. tuberculosis metabolites to activate human mucosal-associated invariant T cells
Shouxiong Huang · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2025 · research · R03
Determining the Functional Significance of Mutations Observed in Envelope Protein Following Serial In Vivo Passaging of Human-Simian Immunodeficiency Virus
Rajesh Thippeshappa · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2024 · career development · K01
Pathogenesis of and host response to chikungunya virus infection of the central nervous system
Victoria K Baxter · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2025 · research · R21
Novel antiviral strategy offering forward capability and reduced risk of escape
Andrew Hayhurst · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2027 · grant · C06
Further expansion of the Southwest National Primate Research Center Specific Pathogen Free Rhesus Macaque Resource
Amber Mallory · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas
Blanca I Restrepo · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2025 · research · R21
Modeling chikungunya virus neuroinvasion and neuropathogenesis in mice
Victoria K Baxter · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2028 · research · R01
M. tuberculosis metabolites to activate human mucosal-associated invariant T cells
Shouxiong Huang · Texas Biomedical Research Institute · funded by National Institutes of Health
2023–2025 · research · R01
Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas
Blanca I Restrepo · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2025 · research · R61
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis
Gillian L Beamer · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2024 · research · R21
Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection
Riti Sharan · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2025 · research · R61
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis
Gillian L Beamer · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2027 · research · R25
It's Contagious! Promoting the Biomedical Workforce Pipeline through Infectious Diseases
Rosemary Riggs · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2025 · research · R21
Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection
Riti Sharan · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
Dhiraj Kumar Singh · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication
Wenhui Hu · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Role of cellular long non-coding RNAs in HIV replication and disease outcome
Smita Kulkarni · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2026 · research · R01
Durable HIV Vaccine Targeting Mucosal Epithelium
Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · funded by National Institutes of Health
2022–2027 · research · R01
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
Dhiraj Kumar Singh · Texas Biomedical Research Institute · funded by National Institutes of Health